Prosecution Insights
Last updated: May 29, 2026

Salk Institute For Biological Studies

9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
6
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
2
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (2)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (44%)
1
Easy (11%)
4
Unknown (44%)

Rejection Statute Mix

BucketCases
§103 only4 (44%)
§112 only1 (11%)
No statute on record4 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SINGH, ANOOP KUMAR 1 42.8% +67.6%
VANHORN, ABIGAIL LOUISE 1 46.7% +22.1%
CORDAS, EMILY ANN 1 50.6% +58.5%
ARON, KIMBERLY A 1 54.1% +35.0%
BATES, KEENAN ALEXANDER 1 46.3% +70.8%
KIM, TAEYOON 1 51.5% +51.4%
LIPPOLIS, ALEXANDRA ROSE 1 36.4% +70.1%
VASSELL, MEREDITH ABBOTT 1 28.8% +47.2%
RAVINDRA, KRISHNA NUGGEHALLI 1 72.7% +3.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17632658 SYSTEMS AND METHODS FOR DISEASE AND TRAIT PREDICTION THROUGH GENOMIC ANALYSIS VASSELL, MEREDITH ABBOTT 4d overdue

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17769524 METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN KIM, TAEYOON 147d overdue
17637058 COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITING LIPPOLIS, ALEXANDRA ROSE 125d overdue
18028751 PATIENT SELECTION BIOMARKERS FOR TREATMENT WITH ULK INHIBITORS VANHORN, ABIGAIL LOUISE 19d overdue
17632658 SYSTEMS AND METHODS FOR DISEASE AND TRAIT PREDICTION THROUGH GENOMIC ANALYSIS VASSELL, MEREDITH ABBOTT 4d overdue
18426803 SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS SINGH, ANOOP KUMAR 7d
18297323 MOTOR NEURON-SPECIFIC EXPRESSION VECTORS ARON, KIMBERLY A 7d
18016251 SONOGENETIC STIMULATION OF CELLS EXPRESSING TRPA1 BATES, KEENAN ALEXANDER 9d
18133237 MEDIA COMPOSITIONS FOR NEURONAL CELL CULTURE CORDAS, EMILY ANN 15d

Top Art Units

Art UnitApps
1632 2
1636 2
1631 2
1633 1
1637 1
1687 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18426803 SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS SINGH, ANOOP KUMAR 1632 Other Non-Final OA 7d Pending Jan 30, 2024
18028751 PATIENT SELECTION BIOMARKERS FOR TREATMENT WITH ULK INHIBITORS VANHORN, ABIGAIL LOUISE 1636 Other Non-Final OA 19d overdue Pending Apr 12, 2023
18133237 MEDIA COMPOSITIONS FOR NEURONAL CELL CULTURE CORDAS, EMILY ANN 1632 §103 Final Rejection 15d Pending Apr 11, 2023
18297323 MOTOR NEURON-SPECIFIC EXPRESSION VECTORS ARON, KIMBERLY A 1633 Other Non-Final OA 7d Pending Apr 07, 2023
18016251 SONOGENETIC STIMULATION OF CELLS EXPRESSING TRPA1 BATES, KEENAN ALEXANDER 1631 Other Non-Final OA 9d Pending Jan 13, 2023
17769524 METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN KIM, TAEYOON 1631 §103 Final Rejection 147d overdue Pending Apr 15, 2022
17637058 COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITING LIPPOLIS, ALEXANDRA ROSE 1637 §103 Non-Final OA 125d overdue Pending Feb 21, 2022
17632658 SYSTEMS AND METHODS FOR DISEASE AND TRAIT PREDICTION THROUGH GENOMIC ANALYSIS VASSELL, MEREDITH ABBOTT 1687 §103 Non-Final OA 4d overdue Pending Feb 03, 2022
17104372 TARGETED GENE ACTIVATION USING MODIFIED GUIDE RNA RAVINDRA, KRISHNA NUGGEHALLI 1636 §112 Final Rejection 34d Pending Nov 25, 2020

Managing Salk Institute For Biological Studies's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month